← TruNorth

INOVIO PHARMACEUTICALS vs SELLAS Life Sciences Group

On overall TruNorth grade, INOVIO PHARMACEUTICALS scores higher (INOVIO PHARMACEUTICALS: B, SELLAS Life Sciences Group: C). Both graded from public records across nine values categories.

B
INOVIO PHARMACEUTICALS
60.6/100
C
SELLAS Life Sciences Group
53.7/100

Political donations

INOVIO PHARMACEUTICALS

FEC: $713K in executive political donations; partisan lean split across 16 executive donors.

SELLAS Life Sciences Group

FEC: $258K in executive political donations; partisan lean Democratic +27 across 14 executive donors.

Environment

INOVIO PHARMACEUTICALS

No public record found.

SELLAS Life Sciences Group

No public record found.

Labor

INOVIO PHARMACEUTICALS

No public record found.

SELLAS Life Sciences Group

2 federal penalties totaling $7.8M since 2000 (Violation Tracker).

DEI

INOVIO PHARMACEUTICALS

No public record found.

SELLAS Life Sciences Group

No public record found.

Charity

INOVIO PHARMACEUTICALS

No public record found.

SELLAS Life Sciences Group

No public record found.

Animal testing

INOVIO PHARMACEUTICALS

No public record found.

SELLAS Life Sciences Group

No public record found.

Firearms

INOVIO PHARMACEUTICALS

No public record found.

SELLAS Life Sciences Group

No public record found.

Privacy

INOVIO PHARMACEUTICALS

No public record found.

SELLAS Life Sciences Group

No public record found.

Executive pay

INOVIO PHARMACEUTICALS

CEO total compensation $1.6M — SEC proxy statement (DEF 14A, 2025). No CEO-to-worker pay ratio disclosed in a parseable form.

SELLAS Life Sciences Group

CEO total compensation $1.2M (2024; other named executives averaged $697K) — SEC pay-versus-performance disclosure (Item 402(v) XBRL).

Compare any two brands on the values you care about — personalized to your 30-second quiz.

Open TruNorth →